The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Aphelion Capital is a healthcare venture capital firm investing in capital efficient products and services that improve patient outcomes at the same or lower cost to the healthcare system.
Venture capitalaphelioncapital.netSince 2025-04-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Biolinq Biolinq sells wearable biosensor technology that monitors glucose levels for health and metabolic insights. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-04-22 | [ PART ] |
No sector on record.